| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Identification of a Lead Compound for the Treatment of Skin Immune Diseases Using Next-Generation TPD Technology Targeting STAT3 | ||||||
| TPD | Atopic dermatitis (Skin immune disease) | STAT3 | Lead | Genexine, Inc. | RS-2025-25455457 | ||
| 2 | Discovery of Selective IRAK4 Degrader based on Protac Technology | ||||||
| TPD | Systemic Lupus Erythematosus | IRAK4 | Lead | College of Pharmacy, Gachon University | RS-2023-00218618 | ||